Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
Using electronic health record data from a national collaboration of pediatric health systems, this study examined the effectiveness of BNT162b2 vaccines for preventing COVID-19 infections and severe disease among previously uninfected children and adolescents.
Qiong Wu, PhD*; Jiayi Tong, MS*; Bingyu Zhang, MS; Dazheng Zhang, MS; Jiajie Chen, PhD; Yuqing Lei, MS; Yiwen Lu, BS; Yudong Wang, PhD; Lu Li, BA; Yishan Shen, MS; Jie Xu, PhD; L. Charles Bailey, MD, PhD; Jiang Bian, PhD; Dimitri A. Christakis, MD, MPH; Megan L. Fitzgerald, PhD; Kathryn Hirabayashi, MPH; Ravi Jhaveri, MD; Alka Khaitan, MD; Tianchen Lyu, MS; Suchitra Rao, MBBS, MSCS; Hanieh Razzaghi, PhD, MPH; Hayden T. Schwenk, MD, MPH; Fei Wang, PhD; Margot I. Gage Witvliet, PhD; Eric J. Tchetgen Tchetgen, PhD; Jeffrey S. Morris, PhD; Christopher B. Forrest, MD, PhD; and Yong Chen, PhD.
